123 related articles for article (PubMed ID: 9510199)
1. Site-directed C3a receptor antibodies from phage display libraries.
Hawlisch H; Frank R; Hennecke M; Baensch M; Sohns B; Arseniev L; Bautsch W; Kola A; Klos A; Köhl J
J Immunol; 1998 Mar; 160(6):2947-58. PubMed ID: 9510199
[TBL] [Abstract][Full Text] [Related]
2. The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression.
Tornetta MA; Foley JJ; Sarau HM; Ames RS
J Immunol; 1997 Jun; 158(11):5277-82. PubMed ID: 9164946
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
Fukuoka Y; Ember JA; Hugli TE
J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
Fukuoka Y; Ember JA; Hugli TE
Biochem Biophys Res Commun; 1998 Jan; 242(3):663-8. PubMed ID: 9464274
[TBL] [Abstract][Full Text] [Related]
5. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
[TBL] [Abstract][Full Text] [Related]
6. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells.
Crass T; Raffetseder U; Martin U; Grove M; Klos A; Köhl J; Bautsch W
Eur J Immunol; 1996 Aug; 26(8):1944-50. PubMed ID: 8765043
[TBL] [Abstract][Full Text] [Related]
7. Ligand binding sites on guinea pig C3aR: point and deletion mutations in the large extracellular loop and vicinity.
Fukuoka Y; Ember JA; Hugli TE
Biochem Biophys Res Commun; 1999 Sep; 263(2):357-60. PubMed ID: 10491297
[TBL] [Abstract][Full Text] [Related]
8. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
DeNardo SJ; DeNardo GL; DeNardo DG; Xiong CY; Shi XB; Winthrop MD; Kroger LA; Carter P
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3213s-3218s. PubMed ID: 10541366
[TBL] [Abstract][Full Text] [Related]
9. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
Gasque P; Singhrao SK; Neal JW; Wang P; Sayah S; Fontaine M; Morgan BP
J Immunol; 1998 Apr; 160(7):3543-54. PubMed ID: 9531317
[TBL] [Abstract][Full Text] [Related]
10. Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.
Sun J; Ember JA; Chao TH; Fukuoka Y; Ye RD; Hugli TE
Protein Sci; 1999 Nov; 8(11):2304-11. PubMed ID: 10595533
[TBL] [Abstract][Full Text] [Related]
11. Role of the second extracellular loop of human C3a receptor in agonist binding and receptor function.
Chao TH; Ember JA; Wang M; Bayon Y; Hugli TE; Ye RD
J Biol Chem; 1999 Apr; 274(14):9721-8. PubMed ID: 10092660
[TBL] [Abstract][Full Text] [Related]
12. Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signaling.
Settmacher B; Rheinheimer C; Hamacher H; Ames RS; Wise A; Jenkinson L; Bock D; Schaefer M; Köhl J; Klos A
Eur J Immunol; 2003 Apr; 33(4):920-7. PubMed ID: 12672058
[TBL] [Abstract][Full Text] [Related]
13. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
14. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy.
Winthrop MD; DeNardo SJ; Albrecht H; Mirick GR; Kroger LA; Lamborn KR; Venclovas C; Colvin ME; Burke PA; DeNardo GL
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3845S-53S. PubMed ID: 14506182
[TBL] [Abstract][Full Text] [Related]
15. The C3a receptor antagonist SB 290157 has agonist activity.
Mathieu MC; Sawyer N; Greig GM; Hamel M; Kargman S; Ducharme Y; Lau CK; Friesen RW; O'Neill GP; Gervais FG; Therien AG
Immunol Lett; 2005 Sep; 100(2):139-45. PubMed ID: 16154494
[TBL] [Abstract][Full Text] [Related]
16. [Cloning and expression of human single-chain Fv antibody against amyloid beta peptide involved in Alzheimer's disease].
Cai J; Wang SZ; Peng Y; Zhong YW; Ji ZJ; Yuan JG; Qiang BQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):557-62. PubMed ID: 14650158
[TBL] [Abstract][Full Text] [Related]
17. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
[TBL] [Abstract][Full Text] [Related]
18. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
Böldicke T; Tesar M; Griesel C; Rohde M; Gröne HJ; Waltenberger J; Kollet O; Lapidot T; Yayon A; Weich H
Stem Cells; 2001; 19(1):24-36. PubMed ID: 11209088
[TBL] [Abstract][Full Text] [Related]
19. Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments.
Kettleborough CA; Ansell KH; Allen RW; Rosell-Vives E; Güssow DH; Bendig MM
Eur J Immunol; 1994 Apr; 24(4):952-8. PubMed ID: 8149964
[TBL] [Abstract][Full Text] [Related]
20. Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
Lienenklaus S; Ames RS; Tornetta MA; Sarau HM; Foley JJ; Crass T; Sohns B; Raffetseder U; Grove M; Hölzer A; Klos A; Köhl J; Bautsch W
J Immunol; 1998 Sep; 161(5):2089-93. PubMed ID: 9725198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
